Article
US M&A Activity: Remedies Return, States Press Forward, And HSR Form Reverts
The Trump 2.0 antitrust agencies demonstrate renewed willingness to negotiate structural remedies for mergers, but Q2 2026 developments reveal that federal clearance alone may not protect deals from state and private challenges. Meanwhile, the HSR filing form has reverted to its legacy version, though new rules may emerge by year-end.
McDermott Will & Schulte